je.st
news
Tag: release
DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26,...
2015-01-09 11:14:58| Biotech - Topix.net
Bayer Aktiengesellschaft 09.01.2015 10:43 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26,...
2015-01-09 10:59:34| Chemicals - Topix.net
Bayer Aktiengesellschaft 09.01.2015 10:43 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Press release distribution, EDGAR filing, XBRL, regulatory filings
2015-01-09 04:53:40| Appliances - Topix.net
Ltd. a wholly owned subsidiary of PartnerRe Ltd. has been license... )--Columbia Property Trust, Inc. announced that it has expanded its holdings in Manhattan and entered Boston's urban core through two acquisitions totaling $588 mi... )--Neal Goldman has been elected to serve as Chairman of Charles & Colvard's Board of Directors, replacing George Cattermole who remains on the Board.
Tags: press
release
distribution
press release
Press release distribution, EDGAR filing, XBRL, regulatory filings
2015-01-09 04:35:18| Footwear - Topix.net
Macy's, Inc. Comparable Sales Rose 2.7% on an Owned Plus Licensed Basis in November/December Period; Comparable Sales Rose 2.1% on an Owned Basis )--Macy's, Inc. today announced that its comparable sales on an owned plus licensed basis rose by 2.7 percent in the months of November and December 2014 combined... )--Deluxe Corporation announces that it will report its 2014 fourth quarter financial results on Thursday, January 22, 2015 prior to market open.
Tags: press
release
distribution
press release
Neurocrine Biosciences surges after release of study results
2015-01-08 18:21:29| Biotech - Topix.net
Shares of Neurocrine Biosciences surged Thursday after drug development partner AbbVie said their potential treatment for endometriosis-related pain fared well in late-stage research. AbbVie said early results from the first of two phase three studies of the drug showed that doses of elagolix met the study's main goals of reducing non-menstrual pelvic pain and menstrual pain in patients with endometriosis.
Tags: results
study
release
biosciences
Sites : [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] [476] [477] [478] next »